Komunikaty PR

CloudIBN Launches Expert vCISO Services: Strategic Cybersecurity Leadership On-Demand

2025-06-16  |  20:55:04
CloudIBN - vCISO Services

CloudIBN - vCISO Services

CloudIBN is proud to introduce its innovative vCISO Services, providing businesses with expert cybersecurity leadership on demand.

MAIMI, FL, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- CloudIBN is proud to introduce its innovative vCISO Services, providing businesses with expert cybersecurity leadership on demand. Tailored for startups, mid-market companies, and enterprises, these services deliver strategic guidance, risk management, compliance support, and incident readiness from seasoned professionals—without the expense or commitment of a full-time executive.

Why vCISO Service Are No Longer Optional
Cybersecurity threats are increasing in scale, speed, and sophistication. As organizations expand their digital footprints, they simultaneously widen their attack surface. While large enterprises typically employ full-time Chief Information Security Officers (CISOs) to steer cybersecurity efforts, small to mid-sized businesses often lack the resources to do the same—leaving them vulnerable and ill-prepared.
CloudIBN’s vCISO Service close this gap by providing executive-level cybersecurity leadership as a service. Whether an organization is building its security strategy from scratch, managing compliance with frameworks like HIPAA, PCI DSS, GDPR, or NIST, or seeking to strengthen its incident response planning, a virtual CISO brings the right expertise exactly when and where it’s needed.

Build a strong cybersecurity foundation with CloudIBN’s virtual CISO expertise. Flexible, cost-effective, and ready when you need it. Learn more and connect today: https://www.cloudibn.com/contact/

What Are vCISO Service and How Do They Work?
vCISO Service (Virtual Chief Information Security Officer Services) are designed to provide organizations with access to experienced cybersecurity leaders without the commitment of hiring a permanent executive. A CloudIBN vCISO is a senior professional with proven experience across cybersecurity strategy, governance, risk, and compliance.

Here's how it works:
1. Initial Risk Assessment
CloudIBN’s vCISO begins with a deep-dive security risk assessment to understand the current state of your infrastructure, regulatory exposure, and organizational goals.
2. Strategic Planning
Based on the findings, a cybersecurity roadmap is developed, tailored to your risk appetite, compliance needs, and business objectives.
3. Policy and Framework Development
The vCISO creates and implements security policies, standards, and procedures aligned with industry best practices such as NIST CSF, ISO 27001, and CIS Controls.
4. Vendor Risk and Compliance Management
Ensure third-party risks are minimized, compliance requirements are met, and audits are successfully passed.
5. Continuous Improvement and Board Reporting
Your vCISO regularly reports on security metrics and risk status to your board or senior leadership while continuously optimizing your security posture.
6. Incident Response Readiness
In the event of a breach or threat, your vCISO leads incident response coordination, minimizing damage and ensuring lessons are learned.

Why CloudIBN is the Smart Choice for vCISO Service
CloudIBN’s vCISO offering stands apart through a combination of experience, agility, and customization. Here’s why clients trust CloudIBN:
1. Certified Security Leadership
Our vCISOs are CISSP, CISA, and CISM certified professionals with years of hands-on leadership experience across critical sectors including finance, healthcare, and technology.
2. Flexible Engagement Models
Whether you need a fractional vCISO, project-based advisory, or long-term oversight, CloudIBN offers engagement plans tailored to your organization’s needs and budget.
3. Global Compliance Expertise
We specialize in helping organizations achieve and maintain compliance with US and global standards like HIPAA, PCI DSS, SOX, ISO 27001, GDPR, and others.
4. Technology-Agnostic Guidance
CloudIBN works independently of vendors, ensuring the solutions recommended are genuinely best for your business.
5. Rapid Onboarding
Our streamlined process allows organizations to benefit from cybersecurity leadership within days—not months.

Minimize risks, ensure compliance, and stay audit-ready with CloudIBN’s flexible vCISO service. Schedule your consultation today: https://www.cloudibn.com/lp/pr-cybersecurity-in-usa/

vCISO Security Service that Scales with Your Business
While the primary value of our vCISO Service lies in leadership and strategy, CloudIBN’s broader vCISO Security Service ecosystem enhances and supports that leadership with the following:
1. Security Program Maturity Assessments
2. Security Awareness & Training Programs
3. Third-party Vendor Risk Management
4. Cloud and Application Security Reviews
5. Disaster Recovery and Business Continuity Planning
6. Threat Intelligence Integration
7. Tabletop Exercises and Incident Simulations
8. These supplementary services work together to deliver end-to-end security leadership that evolves with your organization.

Empower your organization with CloudIBN’s vCISO Security Services—trusted security leadership that evolves alongside your business. From risk management to incident readiness, CloudIBN helps you build a strong, resilient cybersecurity foundation for lasting success. Our flexible, cost-effective solutions ensure you stay compliant with evolving regulations while minimizing risks. Partner with CloudIBN to gain the expertise and confidence needed to navigate today’s complex cybersecurity landscape.

Related Services : Cybersecurity Services - https://www.cloudibn.com/cybersecurity-services/

About CloudIBN 
Founded in 1999, CloudIBN is an ISO 27001:2013, ISO 9001:2015 certified IT and Cybersecurity services provider. As a Microsoft Cloud Managed Services Partner, IBN specializes in VAPT, SIEM-SOAR consulting and deployment, cloud security, and compliance consulting. With a team of experienced lead auditors and cybersecurity specialists, IBN is committed to securing digital infrastructures worldwide

Surendra Bairagi
Cloud IBN
+1 2815440740
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, firmy czy instytucje państwowe.
Ostatnio dodane
komunikaty PR z wybranej przez Ciebie kategorii
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

NEXCOM EBC 370 Powers Autonomous Robotics for Industrial Applications

Highly Efficient, Edge AI Computing Delivered in a Compact New CPUThe EBC 370/EBC 370X is an AI-powered, PC-based controller designed to adapt to the most demanding conditions. Research labs use it as the main control unit for advanced robotics
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 03:55:06

The End Brain Cancer Initiative Partners with Curis to Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial

The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial REDMOND, WA, UNITED STATES, June 16, 2025 /EINPresswire.com/ -- FOR IMMEDIATE RELEASE Contact: Dellann Elliott Mydland, 425-785-8489, Dellann@EndBrainCancer.org The End Brain Cancer Initiative Partners with Curis to Promote Awareness and Pre-qualify for PCNSL TakeAim Lymphoma Clinical Trial The End Brain Cancer Initiative (EBCI) has partnered with Curis to promote awareness and pre-qualify patients for the company’s TakeAim Lymphoma Clinical Trial (CA-4948-101) clinical trial, an open-label, dose escalation and expansion trial of Emavusertib in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/​R PCNSL) (NCT03328078). “We are proud to partner with the End Brain Cancer Initiative to help raise awareness for primary CNS lymphoma (PCNSL), a rare and challenging form of cancer non-Hodgkin lymphoma. Together, we aim to highlight the unmet medical needs of this patient community, provide relevant resources to patients and their care providers, along with increasing awareness of clinical trials,” shared the Chief Medical Officer of Curis Inc, Ahmed Hamdy, MD. “Curis is committed to developing emavusertib for the treatment of PCNSL and broader non-Hodgkin lymphoma indications.” Patients who would like to learn more about this clinical trial and see if they qualify can visit https://endbraincancer.org/curis-therapeutics/ or contact the End Brain Cancer Initiative’s Clinical Research Coordinator and Patient Navigator, Shreya Prakash, at Shreya@EndBrainCancer.org or 425-436-8688. About Curis Curis, located in Lexington, Massachusetts, is a biotechnology company focused on the development of Emavusertib, an orally available, small molecule IRAK4 inhibitor. Emavusertib is currently being evaluated in the TakeAim Lymphoma Phase 1/2 study (CA-4948-101) in patients with relapsed/refractory primary central nervous system lymphoma (PCNSL) in combination with the BTK inhibitor ibrutinib, as a monotherapy in the TakeAim Leukemia Phase 1/2 study (CA-4948-102) in patients with relapsed/refractory acute myeloid leukemia (AML) and relapsed/refractory high risk myelodysplastic syndrome (hrMDS), and as a frontline combination therapy with venetoclax and azacitidine in patents with AML (CA-4948-104). Emavusertib has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of PCNSL, AML and MDS and from the European Commission for the treatment of PCNSL. Curis, through its 2015 collaboration with Aurigene, has the exclusive license to Emavusertib (CA-4948). Curis licensed its rights to Erivedge® to Genentech, a member of the Roche Group, under which they are commercializing Erivedge® for the treatment of advanced basal cell carcinoma. For more information, visit Curis's website at https://www.curis.com/. About the End Brain Cancer Initiative To support/donate to the End Brain Cancer Initiative’s increased access and health delivery for patients, mission, services and programs, please visit EndBrainCancer.org The End Brain Cancer Initiative (EBCI) is a 501(c)3 non-profit patient advocacy organization focused on disease education, awareness, outreach, increasing patient access and improving Standard of Care. The End Brain Cancer Initiative, formerly known as the Chris Elliott Fund (CEF), is dedicated to ensuring that all patients diagnosed with brain cancer, a brain tumor, or metastatic disease to the brain have equal access to advanced diagnostics, treatments, specialists, and clinical trial participation. We believe that IMMEDIATE ACCESS to these options provides this patient community with the best HOPE for survival and sustained quality of life. We partner with industry, patients, researchers, advocacy groups, medical teams, hospital networks and others to educate patients and their caregivers so they can have empowered conversations with their medical teams. Learn more about the End Brain Cancer Initiative or how to sponsor this annual campaign at EndBrainCancer.org. Dellann Elliott Mydland, End Brain Cancer Initiative, 425-785-8489, Dellann@EndBrainCancer.org
EIN Newswire BRAK ZDJĘCIA
2025-06-17 | 02:55:04

Uncle Sharkii Poke Bar Franchisees Honored with Multi-Unit Mastery Award

Uncle Sharkii franchisees Bruno and Jessica Picelli with the 2024 Multi-Unit Mastery Award.The award recognizes the longtime franchisees’ successful leadership and operational excellence across five Uncle Sharkii Poke Bar locations.From day

Kalendarium

Więcej ważnych informacji

Jedynka Newserii

Jedynka Newserii

Kongres Profesjonalistów Public Relations

Ochrona środowiska

Z powodu braku przejrzystego prawa branża recyklingu odkłada inwestycje. Firmy apelują o szybkie wdrożenie przepisów

Branża recyklingu stoi przed wyzwaniami związanymi z wdrożeniem systemu kaucyjnego, systemu rozszerzonej odpowiedzialności producenta i rozporządzenia PPWR. Brakuje jednak odpowiednich przepisów dostosowujących polskie prawo i realia do unijnych regulacji. W efekcie utrzymującej się niepewności prawnej między 2018 a 2023 rokiem co trzeci zakład recyklingu zamknął działalność. Wiele firm odkłada inwestycje, czekając na uregulowanie rynku. Podobna niepewność dotyczy też producentów opakowań. 

Transport

Testowanie pojazdów zautomatyzowanych wkrótce będzie możliwe. To odpowiedź na postulaty przedsiębiorców

Kończą się prace nad przepisami, które mają usprawnić prace badawcze nad pojazdami zautomatyzowanymi. Ma to być odpowiedź na postulaty przedsiębiorców, którzy wskazywali na potrzebę pilnej zmiany przepisów w zakresie testowania pojazdów autonomicznych. Obecne regulacje nie sprzyjają postępowi technologicznemu i rozwoju autonomiczności pojazdów, o czym świadczy bardzo niewielka liczba wydanych uprawnień do ich prowadzenia.

Firma

Przedsiębiorcom coraz bardziej doskwiera niestabilność i skomplikowanie przepisów podatkowych. Problemem są też niejasne ich interpretacje

Polscy przedsiębiorcy często negatywnie oceniają jakość przepisów podatkowych – wynika z raportu „Przedsiębiorcy pod lupą fiskusa 2025” przygotowanego przez firmę doradztwa podatkowego MDDP we współpracy z Konfederacją Lewiatan. Ich niepokój budzą niejednolite interpretacje przepisów i niepewność prawa podatkowego, które cały czas jest modyfikowane. Wśród kluczowych zmian w obszarze podatków, które będą dotyczyć praktycznie wszystkich przedsiębiorców, są m.in. wprowadzenie Krajowego Systemu e-Faktur czy zmiany w podatku od nieruchomości.

Partner serwisu

Instytut Monitorowania Mediów

Szkolenia

Akademia Newserii

Akademia Newserii to projekt, w ramach którego najlepsi polscy dziennikarze biznesowi, giełdowi oraz lifestylowi, a  także szkoleniowcy z wieloletnim doświadczeniem dzielą się swoją wiedzą nt. pracy z mediami.